Apimeds Pharmaceuticals US Price Chart
Apimeds Pharmaceuticals US Volume Chart
Apimeds Pharmaceuticals US Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
-0.11(-7.69%)
| Open | $1.43 |
|---|---|
| Close | $1.32 |
| Low | $1.32 |
| Low Change | -0.11 (-7.69%) |
| High | $1.51 |
| High Change | +0.08 (+5.62%) |
| Range | $0.19 |
| Volume | 20.218K |
| Dollar Volume | $26.69K |
Premarket
+0.00(+0.00%)
| Open | $1.50 |
|---|---|
| Close | $1.50 |
| Low | $1.50 |
| Low Change | 0.00 (0.00%) |
| High | $1.50 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 500 |
| Dollar Volume | $750.00 |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
-0.11(-7.69%)
| Open | $1.43 |
|---|---|
| Close | $1.32 |
| Low | $1.32 |
| Low Change | -0.11 (-7.69%) |
| High | $1.51 |
| High Change | +0.08 (+5.62%) |
| Range | $0.19 |
| Volume | 20.218K |
| Dollar Volume | $26.69K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $1.50 |
|---|---|
| Close | $1.50 |
| Low | $1.50 |
| Low Change | 0.00 (0.00%) |
| High | $1.50 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 500 |
| Dollar Volume | $750.00 |
Apimeds Pharmaceuticals US Moving Averages
| 5 Day Moving Average (SMA5) | $1.44 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.44 |
| 20 Day Moving Average (SMA20) | $1.56 |
| 50 Day Moving Average (SMA50) | $1.55 |
| 100 Day Moving Average (SMA100) | $1.66 |
| 200 Day Moving Average (SMA200) | $1.84 |
Apimeds Pharmaceuticals US Statistics
| Average Volume (30 Days) | 378.52K |
|---|---|
| P/E Ratio (Current) | -.52 |
| EPS (Current) | -$2.69 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$11.04M |
| Cash Ratio | 0.07 |
| Current Ratio | 0.35 |
| Quick Ratio | 0.35 |
| Debt to Equity | 0.06 |
| Enterprise Value | $28.24M |
| EV to EBITDA | -1.19 |
| EV to Sales | — |
| Price to Book | 0.17 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.29% |
| Return on Equity | -0.32% |
Apimeds Pharmaceuticals US Stock Splits
There has been 1 stock split for Apimeds Pharmaceuticals US (APUS). The reverse stock split occured on March 26, 2026 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 26, 2026 | Reverse | 10:1 |
Apimeds Pharmaceuticals US Dividends
There have been no dividends for Apimeds Pharmaceuticals US (APUS).